Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New drug evaluation using exercise-induced bronchospasm.

A C Sprenkle, P P VanArsdel, C W Biermann

    Pediatrics
    |November 11, 1975
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Quality of life in urologic oncology].

    Der Urologe. Ausg. A·1999
    Same author

    Development of a life quality questionnaire in bladder cancer surgery.

    British journal of urology·1995
    Same author

    [Quality assurance in tumor surgery--the effect of tumor surgery interventions on the quality of life of patients with urologic tumors].

    Swiss surgery = Schweizer Chirurgie = Chirurgie suisse = Chirurgia svizzera·1995
    Same author

    [Diagnosis and therapy of primary malignant fibrous histiocytoma of the kidney].

    Swiss surgery = Schweizer Chirurgie = Chirurgie suisse = Chirurgia svizzera·1995
    Same author

    [Primary detection of malignant mesothelioma of the tunica vaginalis testis using the BMA-120 monoclonal antibody].

    Helvetica chirurgica acta·1994
    Same author

    [Bile duct carcinoma after abdominal irradiation for urologic malignancies].

    Helvetica chirurgica acta·1994

    A new xanthone drug shows promise in treating exercise-induced asthma. Oral administration significantly reduced post-exercise bronchospasm in human trials, indicating potential therapeutic benefits.

    Area of Science:

    • Pharmacology
    • Respiratory Medicine
    • Clinical Trials

    Background:

    • Exercise-induced asthma (EIA) is a common condition.
    • Current treatments aim to prevent bronchospasm.
    • Novel therapeutic agents are needed for EIA management.

    Purpose of the Study:

    • To evaluate the efficacy of a novel xanthone compound.
    • To assess the drug's activity in preventing exercise-induced bronchospasm in humans.
    • To determine the time course of the drug's effect.

    Main Methods:

    • A double-blind, cross-over study design was employed.
    • Participants received a single oral dose of 8 mg/kg of the xanthone.
    • Pulmonary function was assessed at two and five hours post-administration.

    Related Experiment Videos

  • Exercise challenge was used to induce bronchospasm.

    • Main Results:

    • The xanthone demonstrated significant inhibition of post-exercise bronchospasm.
    • This effect was most pronounced five hours after drug administration.
    • The drug was orally active and well-tolerated in the study population.

    Conclusions:

    • The novel xanthone exhibits significant activity against exercise-induced asthma in humans.
    • Further research is warranted to optimize dosage and confirm clinical effectiveness.
    • This compound represents a potential new treatment option for EIA.